IP Library Granted Patent US 9,074,222
Granted Patent B2
US 9,074,222 · App. 14/162,663 · Granted Jul 7, 2015

DCX mini-promoters

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,074,222
App. No.
14/162,663
Granted
Jul 7, 2015
Kind
B2
Abstract

Isolated polynucleotides comprising a DCX mini-promoters are provided. The mini-promoter may be operably linked to an expressible sequence, e.g. reporter genes, genes encoding a polypeptide of interest, regulatory RNA sequences such as miRNA, siRNA, anti-sense RNA, etc., and the like. In some embodiments a cell comprising a stable integrant of an expression vector is provided, which may be integrated in the genome of the cell. The promoter may also be provided in a vector, for example in combination with an expressible sequence. The polynucleotides find use in a method of expressing a sequence of interest, e.g. for identifying or labeling cells, monitoring or tracking the expression of cells, gene therapy, etc.

Claims (18)

1. An isolated polynucleotide comprising a DCX mini-promoter wherein the DCX mini-promoter comprises a DCX regulatory element with substantial similarity to SEQ ID NO: 6, 7 or 8 operably joined to an DCX basal promoter with substantial similarity to SEQ ID NO: 4 or 5 wherein the spacing between the DCX regulatory element and the DCX basal promoter is not more than 500 nucleotides (nt).

2. The polynucleotide of claim 1 comprising a DCX minipromoter with substantially similarity to SEQ ID NO: 1.

3. The polynucleotide of claim 1 comprising a DCX mini-promoter with substantial similarity to SEQ ID NO: 2.

4. The isolated polynucleotide of claim 1 , operably linked to an expressible sequence.

5. A vector comprising the isolated polynucleotide of claim 1 .

6. An isolated cell comprising the vector of claim 5 .

7. The cell of claim 6 , wherein the vector is stably integrated into the genome of the cell.

8. The cell of claim 6 or claim 7 , wherein the cell is a stem cell or a retinal cell.

9. A method of expressing a sequence of interest, the method comprising operably linking the sequence of interest to the polynucleotide of claim 1 ; and introducing into a cell permissive for expression from the DCX mini-promoter.

10. An isolated polynucleotide comprising a DCX mini-promoter wherein the DCX mini-promoter comprises a DCX regulatory element with at least 95% sequence identity to SEQ ID NO: 6, 7 or 8 operably joined to an DCX basal promoter with at least 95% sequence identity to SEQ ID NO: 4 or 5, wherein the spacing between the DCX regulatory element and the DCX basal promoter is not more than 500 nucleotides (nt).

11. The polynucleotide of claim 10 , wherein the DCX mini-promoter has at least 95% sequence identity to SEQ ID NO: 1.

12. The polynucleotide of claim 10 wherein the DCX mini-promoter has at least 95% sequence identity to SEQ ID NO: 2.

13. The isolated polynucleotide of claim 10 , operably linked to an expressible sequence.

14. A vector comprising the isolated polynucleotide of claim 10 .

15. An isolated cell comprising the vector of claim 14 .

16. The cell of claim 15 , wherein the vector is stably integrated into the genome of the cell.

17. The cell of claim 15 , wherein the cell is a stem cell or a retinal cell.

18. A method of expressing a sequence of interest, the method comprising operably linking the sequence of interest to the polynucleotide of claim 10 ; and introducing into a cell permissive for expression from the DCX mini-promoter.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2014
From: SIMPSON, ELIZABETH M.; WASSERMAN, WYETH W.; HOLT, ROBERT A.; JONES, STEVEN J.; GOLDOWITZ, DANIEL; PORTALES-CASAMAR, ELODIE; D'SOUZA, CLETUS; CHOPRA, VIKRAMJIT; DE LEEUW, CHARLES
To: THE UNIVERSITY OF BRITISH COLUMBIA
Reel/Frame 032926/0131 →